The past decade has brought substantial advances in the management of inflammatory bowel diseases(IBD).The introduction of tumor necrosis factor(TNF)antagonists
Small intestinal neuroendocrine tumors(SI-NETs)may demonstrate a widely variable clinical behavior but usually it is indolent.In cases with localized disease,lo
Non-invasive diagnostic biomarkers may contribute to an early identification of gastric cancer(GC)and improve the clinical management.Unfortunately,no sensitive